Hospira Reports First-Quarter 20...($9.2 million reported in Selling general...),Health

Date:4/28/2009

$9.2 million reported in Selling, general and administrative. (1) The Non-GAAP financial measures contained in this press release (gross profit, income from operations, net income, and diluted Earnings Per Share) adjust for items that are unusual or nonrecurring. Unusual or nonrecurring items can be highly variable, difficult to predict, and of a size that may substantially impact Hospira's reported results for a period. Management believes that Non-GAAP financial measures can facilitate a complete analysis of Hospira's results of operations, particularly in evaluating performance over time. Management uses these Non-GAAP financial measures internally in financial planning, to monitor business unit performance, and in evaluating management performance. Refer to Hospira's filing on Form 8-K of today's date for additional information. (2) Net sales less Cost of products sold. Hospira, Inc. Condensed Consolidated Balance Sheets (Unaudited) (dollars in millions) March 31, December 31, Assets 2009 2008 -------- -------- Current Assets: Cash and cash equivalents $529.4 $483.8 Trade receivables, less allowances of $7.6 in 2009 and $6.7 in 2008 553.0 583.4 Inventories 834.8 830.5 Deferred income taxes 176.8 172.2 Prepaid expenses and other current assets 45.2 35.7 Other receivables 63.1 43.7
'/>"/>

SOURCE Hospira, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related medicine news :

1. Hospira to Host Conference Call for First-Quarter 2009 Results
2. Hospira to Present at Cowen and Companys 29th Annual Health Care Conference March 17
3. Hospira Expands Board of Directors
4. Hospira Reports Fourth-Quarter and Full-Year 2008 Results
5. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
6. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
7. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
8. Hospira Names Ken Meyers to Lead Human Resources
9. Hospira Reports Third-Quarter 2008 Results
10. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
11. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection